Immunoassay Market
Immunoassay Market - Global Industry Assessment & Forecast
Segments Covered
- By Product Reagents & Kits, Analyzers, Software, Services
- By Technology Chemiluminescent Immunoassay, Radio Immunoassay, Enzyme-Linked Immunoassay, Fluorescence Immunoassay, Other Technologies
- By Specimen Blood, Saliva, Urine, Other Specimens
- By Application Clinical Diagnostics, Research Applications, Other Applications
- By End User Hospitals & Diagnostic Laboratories, Research & Academic Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 29438.72 Million |
Revenue 2030: | USD 47993.78 Million |
Revenue CAGR (2023 - 2030): | 6.3% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Research Methodology: Immunoassay Market by Product by Technology by Specimen by Application by End User by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
The information gained/procured from the secondary data sources is validated through extensive primary interviews with industry experts across the Immunoassay supply chain. The primary research is also conducted to identify key players in the market and to gather and validate already procured information pertaining to their market-specific financial information. Moreover, primary research is used to gain/validate information about:
- Immunoassay market size at regional and country level
- Market size and forecast by Product, Technology, and Specimen
- Key industry players and their market share and Immunoassay market-specific sales/revenue
- Understanding market developments, future growth prospects, and upcoming challenges
- Overview of the Immunoassay supply chain and overall ecosystem
Data Triangulation and Market Size Estimations
After arriving at the global market numbers, top-down and bottom-up approaches are used to estimate, validate and finalize the market size of the Immunoassay market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. During the data triangulation process, the data was analyzed by employing various data models and statistical techniques to arrive at exact statistics and market size for each segment/sub-segment of the market. The data is analyzed and triangulated by considering all the key market impacting factors from both supply and demand side of Immunoassay market.
FAQ
Frequently Asked Question
What is the global demand for Immunoassay in terms of revenue?
-
The global Immunoassay valued at USD 29438.72 Million in 2022 and is expected to reach USD 47993.78 Million in 2030 growing at a CAGR of 6.3%.
Which are the prominent players in the market?
-
The prominent players in the market are Danaher (U.S.), Thermo Fisher Scientific (U.S.), Abbott Laboratories (U.S.), Roche (Switzerland), Siemens Healthineer (Germany), Quidel (U.S.), DiaSorin (Italy), bioMérieux (France), Bio-Rad Laboratories (U.S.), Ortho Clinical Diagnostics (U.S.), PerkinElmer (U.S.), Becton Dickinson & Company (U.S.), Sysmex (Japan), Agilent Technologies (U.S.), Mindray (China), QIAGEN (Netherlands), Merk KGaA (Germany), Bio-Techne (U.S.), Cellabs (Australia), Abnova Corporation (Taiwan), J. Mitra & Co. Pvt. Ltd. (India), Tosoh Corporation (Japan), Cell Sciences (U.S.), Enzo Biochem Inc.(U.S.), Creative Diagnostics (U.S.), Boster Biological Technology (U.S.), Elabscience Inc. (U.S.), WAK-Chemie Medical GmbH (Germany), Sera Care (U.S.), Epitope Diagnostics Inc. (U.S.), Kamiya Biomedical Company (U.S.) Gyros Protein Technologies (Sweden).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 6.3% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Immunoassay include
- introduction of advanced technology
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Immunoassay in 2022.